Moleculent AB
2 known investors
Moleculent develops biological discovery and disease understanding tools for scientists. The company focuses on decoding molecular foundations of biology to advance human health diagnostics and research.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
FR
Fredrik RoosCTO & Co-founder
Investors · 2
In the news
- Medpathtrial.medpath.com · 2026
- Moleculent Raises $20 Million to Scale its Functional Profiling Platform and Accelerate US Expansionfinance.yahoo.com · 2026
- Moleculent Launches with $26 Million Series A Financing | citybizcitybiz.co · 2024
- Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication - BioSpacebiospace.com · 2024